These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 2182054)

  • 1. Therapeutic inequivalence.
    Rheinstein PH
    Drug Saf; 1990; 5 Suppl 1():114-9. PubMed ID: 2182054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
    Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J
    Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential concerns about generic substitution: bioequivalence versus therapeutic equivalence of different amlodipine salt forms.
    Meredith PA
    Curr Med Res Opin; 2009 Sep; 25(9):2179-89. PubMed ID: 19601710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified Regulatory Pathways to Approve Generic Drugs in the US and a Systematic Review of Their Outcomes.
    Kesselheim AS; Polinski JM; Fulchino LA; Isaman DL; Gagne JJ
    Drugs; 2015 Apr; 75(6):633-50. PubMed ID: 25822610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generics and cost-effective prescribing in Belgium: does bioequivalence always translate in therapeutic equivalence?
    Dupont AG; Heller F
    Acta Clin Belg; 2009; 64(5):406-14. PubMed ID: 19999388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Product selection, bioequivalence, and therapeutic equivalence: the generic drug market.
    Halperin JA
    Drug Inf J; 1983; 17(2):73-6. PubMed ID: 10263719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Bioequivalence a Sufficient Measure of Equivalence?
    Holman A
    J Leg Med; 2019; 39(3):247-261. PubMed ID: 31626574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of generic agents in psychopharmacologic treatment.
    Kumet R; Gelenberg AJ
    Essent Psychopharmacol; 2005; 6(2):104-11. PubMed ID: 15765794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioequivalence of generic thioridazine drug products--the FDA viewpoint.
    Hamrell MR; Martinez MN; Dighe SV; Parkman PD
    Drug Intell Clin Pharm; 1987 Apr; 21(4):362-72. PubMed ID: 3569040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status of generic substitution: problematic drug classes reviewed.
    Ross MB
    Hosp Formul; 1989 Aug; 24(8):441-4, 447-9. PubMed ID: 10294356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A generic drug primer: regulatory aspects and scientific concepts.
    Henderson JD; White GL
    Mil Med; 1998 Apr; 163(4):193-7. PubMed ID: 9575760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generics Substitution, Bioequivalence Standards, and International Oversight: Complex Issues Facing the FDA.
    Bate R; Mathur A; Lever HM; Thakur D; Graedon J; Cooperman T; Mason P; Fox ER
    Trends Pharmacol Sci; 2016 Mar; 37(3):184-191. PubMed ID: 26687297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Generic drugs: quality, efficacy, safety and interchangeability].
    Tschabitscher D; Platzer P; Baumgärtel C; Müllner M
    Wien Klin Wochenschr; 2008; 120(3-4):63-9. PubMed ID: 18322766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory aspects of modifications to innovator bronchodilator metered dose inhalers and development of generic substitutes.
    Adams WP; Poochikian G; Taylor AS; Patel RM; Burke GP; Williams RL
    J Aerosol Med; 1994; 7(2):119-34. PubMed ID: 10147277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generic drugs for the treatment of ocular conditions: changing the treatment landscape.
    Aref AA
    Expert Rev Clin Pharmacol; 2014 Sep; 7(5):551-3. PubMed ID: 24957466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generic substitution: issues for problematic drugs.
    Henderson JD; Esham RH
    South Med J; 2001 Jan; 94(1):16-21. PubMed ID: 11213935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community pharmacists' understanding and perceptions of FDA therapeutic equivalence standards.
    Euen BJ; Fadda HM
    Res Social Adm Pharm; 2019 Jan; 15(1):77-83. PubMed ID: 29567088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Generic drugs: we must cut pharmaceutical spending but undertaking drug quality].
    Carrillo Norte JA; Postigo Mota S
    Rev Enferm; 2012 Feb; 35(2):10-9. PubMed ID: 22670381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug substitution in transplantation: a National Kidney Foundation White Paper.
    Sabatini S; Ferguson RM; Helderman JH; Hull AR; Kirkpatrick BS; Barr WH
    Am J Kidney Dis; 1999 Feb; 33(2):389-97. PubMed ID: 10023656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generic drugs and the prescribing physician.
    Nightingale SL; Morrison JC
    JAMA; 1987 Sep; 258(9):1200-4. PubMed ID: 3626003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.